Total Nutraceutical Solutions Receives Approval and Makes Initial Shipment

STEVENSON, Wash.--(Business Wire)--
Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that it
has received approval for importation of ImmuSANO and GlucoSANO from the
Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The
Netherlands Antilles. Caribbean International Medical N.V. ("CIM"), based in
Curacao, is the exclusive distributor for The Netherlands Antilles, Aruba,
Trinadad-Tabago and Suriname with the option to expand to other Caribbean
islands based on certain commercial benchmarks. The initial 1,000 unit shipment
to CIM was sent on Thursday October 29th.

"CIM is an experienced sales and marketing company throughout the Caribbean,"
stated Marvin S. Hausman MD, CEO. "We are very happy to have CIM as a partner to
handle the marketing, sales and distribution of our products in this geographic
area."

"I am very excited that our company has partnered with TNS and we will utilize
all of our expertise to commercialize the unique TNS product line throughout the
Caribbean," stated Lloyd Philbert, CEO of CIM.

About Total Nutraceutical Solutions, Inc.:

Total Nutraceutical Solutions, Inc. (TNS), is an emerging nutraceutical company
with a focus on discovering, formulating and marketing products composed
primarily of organic natural mushroom compounds that contain bioactive nutrients
for potential health benefits. TNS develops production and analytic technologies
for food and nutritional supplements composed primarily of mushrooms and their
mycelial biomasses. Novel clinical models and biomarkers are used to show
nutritional and clinical efficacy of our products. In addition to preventative
healthcare formulations and nutritional approaches to a wide variety of human
conditions and illnesses, TNS also develops and acquires breakthrough
nutritional tools and products in the fields of animal husbandry and livestock
feeds.

Any statements contained in this press release that relate to future plans,
events or performance are forward-looking statements that involve risks and
uncertainties, including, but not limited to, the risks associated with
thetransactiondescribed in this press release, and other risks identified in the
filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and
Exchange Commission. Further information on risks faced by TNS are detailed in
the Form 10-K for the year ended December 31, 2008, and in its subsequent
Quarterly Reports on Form 10-Q. These filings are or will become available on a
website maintained by the Securities and Exchange Commission at
http://www.sec.gov. The information contained in this press release is accurate
as of the date indicated. Actual results, events or performance may differ
materially. TNS does not undertake any obligation to publicly release the result
of any revision to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events.

For Total Nutraceutical Solutions, Inc.
Roberta Matta, 509-427-5132
www.totalnutraceutical.com

Copyright Business Wire 2009